The tirzepatide 60mg pen: what's inside each KwikPen and why the dose matters

You've been told you're moving to 15mg, here's what the 60mg pen actually is

Searching for a "tirzepatide 60mg pen" usually means one thing: your prescriber has mentioned the 15mg dose, and you're trying to understand what arrives. The naming follows the total content of the pen, not the dose per injection. Mounjaro's KwikPen range runs from 2.5mg up through 5mg, 7.5mg, 10mg, 12.5mg and finally 15mg, and the corresponding pen labels read 7.5mg, 15mg, 22.5mg, 30mg, 37.5mg and 60mg. That 60mg figure is simply four lots of 15mg in a single cartridge.

So when the pen you're holding says 60mg on the label, you're not injecting 60mg. You're injecting 15mg, once a week, for four weeks from that one pen. Understanding this distinction matters, because patients who are surprised by the label sometimes worry they've received the wrong product. They haven't. The Mounjaro injection system is designed this way across every strength in the range.

One practical note: the pen locks automatically after the fourth use, so there's no guesswork about whether a dose remains. Used pens should go into a sharps container rather than general waste, your local council or pharmacy can advise on collection points.

Why reaching the 15mg dose takes time, and why that's intentional

Tirzepatide treatment starts at 2.5mg. That first pen exists to help your body adjust to the medicine, particularly your gut, before the dose does any meaningful therapeutic work. From there, the prescriber steps the dose upward, typically every four weeks, checking in on how you're tolerating each level before moving higher. The 30mg pen, which delivers four doses of 7.5mg, the 37.5mg pen (four doses of 10mg), the 45mg pen (four doses of 12.5mg), each is a rung on a ladder your prescriber climbs with you.

By the time you reach the 60mg pen, several months of treatment have usually passed. That's not a flaw in the system. The titration schedule exists to reduce the gastrointestinal side effects (nausea, loose stools, reflux) that are most common early in treatment or after a step up. Arriving at 15mg on your own timeline, at the pace your body allows, tends to produce better tolerability than rushing there.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, found average weight reductions of around 20–21% over 72 weeks at the 15mg dose, figures that inform how NICE assessed tirzepatide in its technology appraisal TA1026. Those results were achieved through the full titrated schedule, not by starting at the top dose.

Side effects at 15mg: what tends to change as the dose rises

Most people who reach the tirzepatide pen at 15mg will have already met the medicine's common side-effect profile at lower doses. That's actually reassuring, your system is adapted. Still, any dose increase can bring a temporary return of nausea, loose stools or fatigue, and moving to the 90mg pen, which some patients encounter if they restart or restock at the 15mg maintenance dose, is no exception. These effects typically settle within a week or two as your body adjusts to the new level.

A less common but serious risk worth naming clearly: acute pancreatitis. The MHRA highlighted this in a January 2026 Drug Safety Update for GLP-1 medicines. If you develop severe, persistent stomach pain that seems to spread toward your back, with or without vomiting, that's a symptom that needs urgent medical attention, not a side effect to wait out. Stop the injection and contact a doctor or 111 the same day.

Other symptoms that warrant prompt attention include signs of a severe allergic reaction, significant mood changes, or symptoms of gallbladder problems such as sharp upper-right abdominal pain. For a thorough list, the patient information leaflet supplied with your pen is the definitive reference. You can also report unexpected effects through the MHRA's Yellow Card scheme.

Getting to 15mg through a private prescription, what the process looks like at nume

Reaching the highest dose of tirzepatide requires clinical oversight at every step. At nume, that means each repeat order (including any dose increase to the 60mg pen) is reviewed by a GPhC-registered Independent Prescriber before it's approved. A real clinician reads your case, not a piece of software. We ask for evidence that the previous dose has been tolerated appropriately before moving you forward; this isn't bureaucracy for its own sake, it's how safe titration works in practice.

If you're already on treatment elsewhere and considering a move, our FAQs cover what transfer patients need to bring. For anyone still weighing up whether tirzepatide is the right direction, the weight loss treatment overview sets out the full picture. Pricing context (what a full course typically costs privately, and what that includes) is covered on our Mounjaro cost page. And if you're at the point of wanting a clinical assessment, orders placed before 12pm on a working day are reviewed and, where clinically suitable, dispatched the same afternoon by tracked DPD delivery.

A free consultation is the first step. Start yours here.